Keyphrases
Esophageal Squamous Cell Carcinoma
100%
Nanog
74%
Gallbladder Cancer
64%
Prognostic Significance
60%
Tumor
58%
Gastric Cancer
46%
MicroRNA
45%
KLF4
43%
Desmoid Tumor
40%
Abdominal Wall
40%
Aquaporin 5 (AQP5)
40%
Cluster of Differentiation 44 (CD44)
40%
GLUT3
40%
Carbon Ion Radiotherapy
40%
Gastric Cancer Patients
39%
Tissue Microarray
37%
Breast Cancer Patients
35%
Glucose Transporter 1 (GLUT1)
32%
Resection
29%
Induced Pluripotent Stem Cells (iPSCs)
28%
Esophageal Cancer
28%
Carcinoma Cell Lines
27%
Circulating Tumor Cells
24%
Metastatic Breast Cancer
23%
Preoperative Chemotherapy
23%
Formalin-fixed Paraffin-embedded Tissue
23%
Perforation
23%
Aquaporin
22%
Human Gallbladder
22%
Breast Cancer
21%
Inducing Factors
21%
Expression Level
21%
Sex-determining Region Y-box 2 (SOX2)
20%
Expression Analysis
20%
Salvage Esophagectomy
20%
New Humanities
20%
Biliary Tract Carcinoma
20%
Pancreas
20%
One-stage Breast Reconstruction
20%
Older Breast Cancer
20%
Perforator Flap Surgery
20%
Barium Peritonitis
20%
CD44v9
20%
Core Needle Biopsy
20%
MiR-203
20%
Autoimmune Pancreatitis
20%
Esophageal Leiomyoma
20%
Definitive Chemoradiotherapy (dCRT)
20%
Inflammatory Response
20%
85-year-old
20%
Medicine and Dentistry
Esophageal Squamous Cell Carcinoma
81%
Neoplasm
64%
microRNA
47%
Surgery
41%
Abdominal Wall
40%
Desmoid Tumor
40%
Ion Therapy
40%
Glucose Transporter 3
40%
Aquaporin 5
40%
Gallbladder Carcinoma
38%
Glucose Transporter 1
30%
Esophagectomy
28%
Gemcitabine
25%
Breast Cancer
25%
Xenograft
23%
Cell Marker
23%
Serositis
23%
Diagnosis
23%
Fluorine-18
23%
Fluorodeoxyglucose
23%
Aquaporin
22%
Gallbladder Carcinoma Cell Line
22%
Biological Marker
22%
Esophagus
21%
Flap (Surgery)
20%
Tail
20%
Needle Biopsy
20%
Gastrointestinal Stromal Tumor
20%
Breast Reconstruction
20%
Deep Inferior Epigastric Perforator Flap
20%
Autoimmune Pancreatitis
20%
Cancer Stem Cell
20%
Peritonitis
20%
Metastatic Breast Cancer
20%
Cholangiocarcinoma
20%
Epithelium
20%
Obturator Hernia
20%
Circulating Tumor Cell
20%
Epithelial Cell Adhesion Molecule
20%
Chemoradiotherapy
20%
Fluorodeoxyglucose F 18
20%
Clinical Study
20%
Hyperthermia
20%
Cholecystitis
20%
Metastatic Carcinoma
20%
Intestine
20%
Pancreaticoduodenectomy
20%
Glucose Transporter 4
20%
Angioleiomyoma
20%
Abdominal Cancer
20%